Home/Filings/4/0001898799-26-000002
4//SEC Filing

Buten Matthew 4

Accession 0001898799-26-000002

CIK 0001935979other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 9:33 PM ET

Size

8.9 KB

Accession

0001898799-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-05
Buten Matthew
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2026-01-05+4,250198,246 total
  • Tax Payment

    Common Shares

    2026-01-05$9.93/sh2,594$25,758195,652 total
  • Exercise/Conversion

    Restricted Share Unit Award

    2026-01-054,2508,500 total
    Common Shares (4,250 underlying)
Footnotes (5)
  • [F1]This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025.
  • [F2]No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
  • [F3]Each restricted share unit represents the contingent right to receive one common share of the Issuer.
  • [F4]The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.
  • [F5]Not applicable.

Issuer

Biohaven Ltd.

CIK 0001935979

Entity typeother

Related Parties

1
  • filerCIK 0001898799

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 9:33 PM ET
Size
8.9 KB